| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $18K | -74.3% | -49.6% |
| Cost of Revenue | $4K | -82.7% | -68.9% |
| Gross Profit | $14K | -70.3% | -39.1% |
| R&D Expense | $227K | +0.3% | +26.9% |
| SG&A Expense | $1.4M | +58.9% | -28.1% |
| Operating Income | -$2.3M | -44.7% | +6.5% |
| Interest Expense | -$2K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $590K | +36.8% | +624.7% |
| Short-term Investments | $3.8M | -29.8% | -16.6% |
| Accounts Receivable | $8K | -86.8% | -47.8% |
| Inventory | $160K | -7.4% | +1.2% |
| Current Assets | $4.8M | -23.2% | -1.8% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.8M | — | — |
| Investing Cash Flow | -$821K | — | — |
| Financing Cash Flow | $4.6M | — | — |
| +51.2% |
| -128.8% |
| Pre-tax Income | -$2.3M | -44.0% | +7.0% |
| Net Income | -$2.3M | -44.0% | +7.0% |
| EPS (Basic) | -$0.13 | -30.0% | +43.5% |
| EPS (Diluted) | -$0.13 | -30.0% | +43.5% |
| $5.1M |
| -21.9% |
| -2.5% |
| Current Liabilities | $358K | -40.5% | +19.4% |
| Total Liabilities | $358K | -40.5% | +19.4% |
| Stockholders' Equity | $4.8M | -20.0% | -3.8% |